Testicular natural killer T-cell lymphoma

Int J Urol. 2005 Feb;12(2):223-4. doi: 10.1111/j.1442-2042.2005.01007.x.

Abstract

Primary testicular lymphomas account for less than 5% of all testicular neoplasms. Testicular natural killer (NK)/T-cell lymphomas are exceptional and have a very poor prognosis. We report the case of a 30-year-old French Caucasian man with testicular NK/T-cell lymphoma of the following immunophenotype: CD2+, CD3epsilon+ and CD56+. Despite intensive chemotherapy, the disease progressed rapidly, with death occurring 2 months after diagnosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies / immunology
  • Antigens, CD / immunology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • CD56 Antigen / immunology
  • Fatal Outcome
  • Humans
  • Intracellular Signaling Peptides and Proteins / immunology
  • Killer Cells, Natural / pathology*
  • Leukosialin
  • Lymphoma, T-Cell / pathology*
  • Lymphoma, T-Cell / therapy
  • Male
  • Orchiectomy
  • RNA Polymerase I
  • Sialoglycoproteins / immunology
  • Testicular Neoplasms / pathology*
  • Testicular Neoplasms / therapy

Substances

  • Antibodies
  • Antigens, CD
  • CD56 Antigen
  • Intracellular Signaling Peptides and Proteins
  • Leukosialin
  • SPN protein, human
  • Sialoglycoproteins
  • POLR1G protein, human
  • RNA Polymerase I